UB Paderborn / Katalog / Suche / in CDI

European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology, 2009-03, Vol.8 (1), p.57-61

2009

Link zum Volltext

Verfügbarkeit prüfen

THU-093 - Predictive factors of tumor recurrence and death in patients with hepatocellular carcinoma treated by locoregional therapies: results of a retrospective cohort study

Journal of hepatology, 2017, Vol.66 (1), p.S217-S217

2017

Link zum Volltext

Verfügbarkeit prüfen

Tuberculosis incidence in Turin, Italy, 1973-1999

The international journal of tuberculosis and lung disease, 2004-02, Vol.8 (2), p.171

2004

Link zum Volltext

Verfügbarkeit prüfen

Gender health and policies: the state of the art from exposure to solutions

Journal of preventive medicine and hygiene, 2009-03, Vol.50 (1), p.58-75

2009

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of Therapies for Heroin Addiction in Retaining Patients in Treatment: Results From the VEdeTTE Study

Substance use & misuse, 2010-10, Vol.45 (12), p.2076-2092

2010

Link zum Volltext

Verfügbarkeit prüfen

Determinants of social inequalities in health in Italy

Annali di igiene, 2000-01, Vol.12 (1 Suppl 1), p.67

2000

Link zum Volltext

Verfügbarkeit prüfen

MRI activity and neutralising antibody as predictors of response to interferon treatment in multiple sclerosis

Journal of neurology, neurosurgery and psychiatry, 2008-06, Vol.79 (6), p.646-651

2008

Link zum Volltext

Verfügbarkeit prüfen

Patterns of drug use among young men in Piedmont (Italy)

Drug and alcohol dependence, 2001-11, Vol.64 (3), p.329-335

2001

Link zum Volltext

Verfügbarkeit prüfen

Neutralizing antibodies in multiple sclerosis patients treated with 375 is a subset of g interferon- beta -1b

Expert opinion on biological therapy, 2009-04, Vol.9 (4), p.387-397

2009

Link zum Volltext

Verfügbarkeit prüfen

MRI activity and neutralising antibody as predictors of response to interferon β treatment in multiple sclerosis. Commentaries

Journal of neurology, neurosurgery and psychiatry, 2008, Vol.79 (6)

2008

Link zum Volltext

Verfügbarkeit prüfen

The OPTimization of Interferon for MS Study: 375 [mu]g interferon beta-1b in suboptimal responders

Journal of neurology, 2008-09, Vol.255 (9), p.1315

2008

Link zum Volltext

Verfügbarkeit prüfen

The OPTimization of interferon for MS study: 375 microg interferon beta-1b in suboptimal responders

Journal of neurology, 2008-09, Vol.255 (9), p.1315-1323

2008

Link zum Volltext

Verfügbarkeit prüfen

Every-other-day interferon beta-1 b versus once-weekly interferon beta-1a for multiple sclerosis (INCOMIN Trial). II: analysis of MRI responses to treatment and correlation with NAb

Multiple sclerosis, 2006, Vol.12 (1), p.72-76

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 88

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(73)

Publikationsform

Artikel
(86)
Buchkapitel
(2)

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Risk Factors for Primary Open Angle Glaucoma (POAG) Progression: A Study Ruled in Torino

Methadone maintenance at different dosages for opioid dependence

School-based prevention for illicit drugs' use

Predictive factors of tumor recurrence and death in patients with hepatocellular carcinoma treated by locoregional therapies: results of a retrospective cohort study

MRI activity and neutralising antibody as predictors of response to interferon β treatment in multiple sclerosis

Decennial Trends of Social Differentials in Smoking Habits in Italy

The OPTimization of Interferon for MS Study: 375 μg interferon beta-1b in suboptimal responders

Recreational drug consumers: who seeks treatment?

Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)

Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis (INCOMIN Trial) II: analysis of MRI responses to treatment and correlation with NAb

Pre-eclampsia or chronic kidney disease? The flow hypothesis

Neutralizing antibodies in multiple sclerosis patients treated with 375 μg interferon-β-1b

Effectiveness of an Informative Video on Reducing Anxiety Levels in Patients Undergoing Elective Coronarography: An RCT

THU-093 - Predictive factors of tumor recurrence and death in patients with hepatocellular carcinoma treated by locoregional therapies: results of a retrospective cohort study

Tuberculosis incidence in Turin, Italy, 1973-1999

Gender health and policies: the state of the art from exposure to solutions

Effectiveness of Therapies for Heroin Addiction in Retaining Patients in Treatment: Results From the VEdeTTE Study

Determinants of social inequalities in health in Italy

MRI activity and neutralising antibody as predictors of response to interferon treatment in multiple sclerosis

Patterns of drug use among young men in Piedmont (Italy)

Neutralizing antibodies in multiple sclerosis patients treated with 375 is a subset of g interferon- beta -1b

MRI activity and neutralising antibody as predictors of response to interferon β treatment in multiple sclerosis. Commentaries

The OPTimization of Interferon for MS Study: 375 [mu]g interferon beta-1b in suboptimal responders

The OPTimization of interferon for MS study: 375 microg interferon beta-1b in suboptimal responders

Every-other-day interferon beta-1 b versus once-weekly interferon beta-1a for multiple sclerosis (INCOMIN Trial). II: analysis of MRI responses to treatment and correlation with NAb

Suchergebnisse filtern